Achieve Life Sciences Inc

ACHV.US
Healthcare · Biotechnology
6.18
+0.00 (+0.00%)
USD · NASDAQ

Company Information

Company Name
Achieve Life Sciences Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US0044685008
CIK: 0000949858
CUSIP: 835692104
Currency: USD
Full Time Employees: 28
Phone: 604 210 2217
Fiscal Year End: December
IPO Date: Oct 13, 1995
Description:

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Address:

22722 29th Dr. SE, Bothell, WA, United States, 98021

People

Directors & Officers

Name Title Year Born
Mr. Erik Atkisson Chief Legal Officer 1972
Dr. Andrew D. Goldberg M.D. CEO, President & Director 1982
Mr. Mark K. Oki CPA Chief Financial Officer 1969
Mr. Craig Donnelly Chief Operations Officer 1977
Mr. Jerry Wan VP of Finance & Principal Accounting Officer 1982
Dr. Mark L. Rubinstein M.D. Chief Medical Officer 1968
Mr. Mark Zappia Senior Vice President of Commercial NA
Ms. Nicole P. Jones Vice President of Strategic Communications & Stakeholder Relations NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 18, 2025 Mark K Oki N/A Sale 50.06K $2.92 $146.18K
Sep 18, 2025 Richard Alistair Stewart N/A Sale 129.50K $2.92 $378.14K
Sep 04, 2025 Cindy Jacobs N/A Sale 27.63K $2.77 $76.53K
Sep 04, 2025 Jaime Xinos N/A Sale 20.85K $2.77 $57.77K
Sep 04, 2025 Jerry Wan N/A Sale 14.07K $2.77 $38.97K
Sep 04, 2025 Thomas Braxton King N/A Sale 139.86K $2.77 $387.41K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Franklin Resources Inc 4.37M Mar 31, 2026 4.26% $0.00 0.00%
Propel Bio Management LLC 3.79M Mar 31, 2026 3.69% $7.17 0.00%
Vanguard Group Inc 2.47M Dec 31, 2025 2.41% $0.00 0.51%
Vanguard Capital Management, LLC 2.20M Mar 31, 2026 2.15% $0.00 0.00%
Simplify Asset Management Inc. 1.43M Jun 30, 2026 1.40% $0.13 20.90%
Millennium Management LLC 1.08M Mar 31, 2026 1.05% $0.00 -20.73%
Marshall Wace Asset Management Ltd 1.02M Mar 31, 2026 0.99% $0.00 0.00%
LPL Financial Corp 728.45K Mar 31, 2026 0.71% $0.00 15.05%
Nantahala Capital Management, LLC 648.89K Mar 31, 2026 0.63% $0.07 0.00%
Geode Capital Management, LLC 622.79K Mar 31, 2026 0.61% $0.00 3.86%
Two Sigma Investments LLC 588.55K Mar 31, 2026 0.57% $0.00 -21.38%
KVP Capital Advisors, LP 462.36K Mar 31, 2026 0.45% $1.02 0.00%
BlackRock Inc 439.36K Mar 31, 2026 0.43% $0.00 4.83%
Susquehanna International Group, LLP 383.68K Mar 31, 2026 0.37% $0.00 -22.70%
UBS Group AG 326.27K Mar 31, 2026 0.32% $0.00 14.39%
Vanguard Fiduciary Trust Co 316.18K Mar 31, 2026 0.31% $0.00 0.00%
State Street Corp 254.46K Mar 31, 2026 0.25% $0.00 8.62%
Northern Trust Corp 224.74K Mar 31, 2026 0.22% $0.00 -2.23%
Two Sigma Advisers, LLC 209.90K Dec 31, 2025 0.20% $0.00 90.30%
Shay Capital LLC 205.11K Mar 31, 2026 0.20% $0.05 -12.69%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 3.11M 3.03% ▲ 98.53% Jun 30, 2026
2 iShares Russell 2000 ETF 2.01M 1.95% ▲ 0.60% Jun 30, 2026
3 Franklin Biotechnology Discv A(acc)USD 1.93M 1.88% ▼ 30.85% Jun 30, 2026
4 Simplify Propel Opportunities ETF 1.43M 1.40% ▲ 0.00% Jun 30, 2026
5 State Street® SPDR® S&P® Biotech ETF 1.34M 1.31% ▼ 2.18% Jun 30, 2026
6 Franklin Biotechnology Discovery A 1.10M 1.07% ▼ 30.46% Jun 30, 2026
7 Vanguard Institutional Extnd Mkt Idx Tr 957.10K 0.93% ▲ 60.00% Jun 30, 2026
8 iShares Russell 2000 Growth ETF 728.21K 0.71% ▼ 0.38% Jun 30, 2026
9 Russell 2000 Equity Index Fund B 514.16K 0.50% ▲ 0.00% Jun 30, 2026
10 Russell 2000 Index Non-Lendable Fund 514.16K 0.50% ▲ 0.00% Jun 30, 2026

Financial Highlights

Market Cap: $634.43M
EBITDA: $-52.23M
PEG Ratio: $17.68
Book Value: $0.20
Earnings/Share: $-1.08
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -108.43%
ROE (TTM): -496.15%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $620.63M
Trailing P/E: 0.00
Forward P/E: 35.34

Shares Statistics

Shares Outstanding: 102.66M
Shares Float: 87.47M
% Insiders: 93.00%
% Institutions: 6,423.60%
Short % Float: 14.43%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-228.00K
Gross Profit
subtotal
$-228.00K
SG&A
adjust
$-31.87M
R&D
adjust
$-22.96M
Operating Income
subtotal
$-54.88M
Other / Non-Operating Items
adjust
$232.00K
Net Income
subtotal
$-54.65M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ACHV.US!